Fundai

Barekat Pharmaceutical Group (BAREKAT) income statement

Operating revenue through to net profit and earnings per share

Ticker
BAREKAT
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31
درآمد سود تضمین شده323,7937,78838312,167
Other income799,8170000
Total operating revenue799,849318,2857,7881,37829,196
هزینه های حقوق، دستمزد و مزایا-485,936-283,819-242,892-223,217-139,922
Depreciation expense-9,825-9,676-6,531--
Other expenses-116,434-89,141-52,94500
جمع هزینه های عملیاتی-612,195-390,886-308,968-223,217-139,922
Operating profit (loss)187,654-72,601-301,180-221,839-110,726
Finance costs-224,349-215,265-276,232-231,605-94,143
Other non-operating income and expenses8,31915,9410-3,415385,951
Profit (loss) from continuing operations before tax-28,376-271,925-577,412-456,859181,082
Net profit (loss) from continuing operations-28,376-271,925-577,412-456,859181,082
Net profit (loss)-28,376-271,925-577,412-456,859181,082
Operating (rials)11-4-18-30-15
Non-operating (rials)-13-12-16-3240
Arising from continuing operations-2-16-34--
سود (زیان) پایه هر سهم (ریال)-2 rials-16 rials-34 rials-62 rials25 rials
سود (زیان) خالص هر سهم (ریال)-1 rials-15 rials-33 rials-62 rials25 rials
Capital17,340,00017,340,00017,340,0007,340,0007,340,000

Reporting periods

32 periods are on file for this report, from the period ending 1395/12/30 to the period ending 1405/06/31.